PAWR and prostate carcinoma: In this last study, Par-4 knock-down does not alter total GRP78 levels in whole-cell lysates, but decreases the cell surface GRP78 expression in prostate cancer cells, suggesting that endogenous Par-4 is involved in the cell surface expression of GRP78.